These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11465299)

  • 1. Economic evaluation of systemic treatments for cytomegalovirus retinitis in patients with AIDS.
    Lee TA; Sullivan SD; Veenstra DL; Ramsey SD; Steger PJ; Malinverni R; Pleil AM; Williamson T
    Pharmacoeconomics; 2001; 19(5 Pt 2):535-50. PubMed ID: 11465299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New developments in the treatment of CMV retinitis.
    Freeman WR
    Ophthalmology; 1996 Jul; 103(7):999-1000. PubMed ID: 8684813
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic options for resistant cytomegalovirus retinitis.
    Kuppermann BD
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 14 Suppl 1():S13-21. PubMed ID: 9058613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New issues in the management of cytomegalovirus retinitis in AIDS patients.
    Pau AK
    Am J Health Syst Pharm; 1998 Feb; 55(4):392-5. PubMed ID: 9504201
    [No Abstract]   [Full Text] [Related]  

  • 5. Randomized, controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS.
    Lalezari JP; Holland GN; Kramer F; McKinley GF; Kemper CA; Ives DV; Nelson R; Hardy WD; Kuppermann BD; Northfelt DW; Youle M; Johnson M; Lewis RA; Weinberg DV; Simon GL; Wolitz RA; Ruby AE; Stagg RJ; Jaffe HS
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):339-44. PubMed ID: 9525435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I/II study of intravitreal cidofovir for the treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
    Kirsch LS; Arevalo JF; De Clercq E; Chavez de la Paz E; Munguia D; Garcia R; Freeman WR
    Am J Ophthalmol; 1995 Apr; 119(4):466-76. PubMed ID: 7709971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of CMV retinitis in HIV infected patients.
    Katlama C
    Genitourin Med; 1997 Jun; 73(3):169-73. PubMed ID: 9306895
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
    Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management strategies for patients with cytomegalovirus retinitis.
    Hardy WD
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 14 Suppl 1():S7-12. PubMed ID: 9058612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial.
    Lalezari JP; Stagg RJ; Kuppermann BD; Holland GN; Kramer F; Ives DV; Youle M; Robinson MR; Drew WL; Jaffe HS
    Ann Intern Med; 1997 Feb; 126(4):257-63. PubMed ID: 9036797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis. The Cytomegalovirus Retinitis and Viral Resistance Study Group.
    Jabs DA; Enger C; Forman M; Dunn JP
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2240-4. PubMed ID: 9736542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis.
    Walton RC; Whitcup SM; Mueller BU; Lewis LL; Pizzo PA; Nussenblatt RB
    Ophthalmology; 1995 Dec; 102(12):1865-70. PubMed ID: 9098289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and experimental therapeutic options for cytomegalovirus disease.
    Flaherty JF
    Am J Health Syst Pharm; 1996 Apr; 53(8 Suppl 2):S4-11. PubMed ID: 8728375
    [No Abstract]   [Full Text] [Related]  

  • 14. Local therapy for cytomegalovirus retinitis.
    Smith CL
    Ann Pharmacother; 1998 Feb; 32(2):248-55. PubMed ID: 9496411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus retinitis: new developments in prophylaxis and therapy.
    Jacobson MA
    AIDS Clin Rev; 1997-1998; ():249-69. PubMed ID: 9305451
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical failure of CMV retinitis with intravitreal cidofovir is associated with antiviral resistance.
    Smith IL; Taskintuna I; Rahhal FM; Powell HC; Ai E; Mueller AJ; Spector SA; Freeman WR
    Arch Ophthalmol; 1998 Feb; 116(2):178-85. PubMed ID: 9488269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of cytomegalovirus retinitis in patients with AIDS.
    Jabs DA
    Ann Intern Med; 1996 Jul; 125(2):144-5. PubMed ID: 8678370
    [No Abstract]   [Full Text] [Related]  

  • 18. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.
    Jabs DA
    Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promising new treatments for cytomegalovirus retinitis.
    Polis MA; Masur H
    JAMA; 1995 May; 273(18):1457-9. PubMed ID: 7723160
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravitreal cidofovir for the maintenance treatment of cytomegalovirus retinitis.
    Rahhal FM; Arevalo JF; Munguia D; Taskintuna I; Chavez de la Paz E; Azen SP; Freeman WR
    Ophthalmology; 1996 Jul; 103(7):1078-83. PubMed ID: 8684797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.